Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inovio Pharmaceuticals

1.97
+0.02001.03%
Pre-market: 1.92-0.0500-2.54%08:31 EST
Volume:420.82K
Turnover:824.35K
Market Cap:71.12M
PE:-0.44
High:2.00
Open:1.95
Low:1.91
Close:1.95
Loading ...

BRIEF-Immune Response Data For INO-3107 To Be Presented As A Poster At American Association For Cancer Research Immuno-Oncology Conference

Reuters
·
10 Feb

Immune Response Data for Ino-3107 to Be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (Aacr-IO) Conference

THOMSON REUTERS
·
10 Feb

Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference

PR Newswire
·
10 Feb

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
08 Feb

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
06 Feb

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
04 Feb

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
31 Jan

INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

PR Newswire
·
30 Jan

Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
29 Jan

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
28 Jan

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
25 Jan

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
22 Jan

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
17 Jan

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
14 Jan

Inovio price target lowered to $3 from $5 at H.C. Wainwright

TIPRANKS
·
13 Jan

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
11 Jan